Thrombocytopenia or haemorrhage5 (Subnet based on 13 studies including 2744 participants) · patients at any age with solid cancer or haematological malignancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thrombocytopenia or haemorrhage5 (Subnet based on 13 studies including 2744 participants) · patients at any age with solid cancer or haematological malignancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thrombocytopenia · people undergoing bariatric surgery
It is very uncertain whether heparin changes adverse events (thrombocytopenia) compared with pentasaccharide (very low certainty).
1 finding from 1 review
Thrombocytopenia · people undergoing bariatric surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thrombocytopenia · people undergoing bariatric surgery
It is very uncertain whether higher‐dose heparin changes adverse events (thrombocytopenia) compared with standard‐dose heparin (very low certainty).
1 finding from 1 review
Intervention not reported
Letter with fixed appointment versus letter with open invitation to make appointment: uptake of screening · women for cervical screening
The intervention probably leads to higher letter with fixed appointment versus letter with open invitation to… (moderate certainty).
1 finding from 1 review
Thrombocytopenia · patients with cancer with venous thromboembolism
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thrombocytopenia · patients with the initial treatment of venous thromboembolism in patients with cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thrombocytopenia · patients with cancer with venous thromboembolism
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Febrile neutropenia · neoadjuvant treatment of ER‐positive vs ER‐negative breast cancer
Capecitabine‐containing regimens showed no clear difference in febrile neutropenia compared with non‐capecitabine‐containing regimens (moderate certainty).
1 finding from 1 review
Febrile neutropenia · patients with early breast cancer
Capecitabine‐containing regimens probably leads to lower febrile neutropenia compared with non‐capecitabine‐containing regimens or no chemotherapy (moderate certainty).
1 finding from 1 review
Maximal mouth opening (interincisal distance) · Adults (general and hospital populations assessed in case-control studies)
Systemic sclerosis patients have significantly reduced mouth opening compared with controls (SMD -1.06); certainty ungraded.
1 finding from 1 review
Trismus / maximum mouth opening (mean) · Adults with mandibular third molars requiring removal
Fibrin sealant led to higher trismus / maximum mouth opening (mean) compared with conventional suturing; GRADE not reported.
1 finding from 1 review
Maximal mouth opening (interincisal distance) · Adults with mandibular third molars requiring removal
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maximal mouth opening (interincisal distance) · Adults with mandibular third molars requiring removal
Surgical drain (tube or gauze) led to higher maximum mouth opening (mean) compared with no drain; GRADE not reported.
1 finding from 1 review
Adverse effects: leukopenia · SSNS in children
It is very uncertain whether mycophenolate mofetil changes adverse effects: leukopenia compared with levamisole (very low certainty).
1 finding from 1 review
Adverse effects: lymphopenia · SSNS in children
Mycophenolate mofetil showed no clear difference in adverse effects: lymphopenia compared with cyclosporin (low certainty).
1 finding from 1 review
Adverse effects: leucopenia · SSNS in children
Levamisole showed no clear difference in adverse effects: leucopenia compared with steroids or placebo or both, or no treatment (low certainty).
1 finding from 1 review
Adverse effects: leucopenia · SSNS in children
Levamisole showed no clear difference in adverse effects: leucopenia compared with cyclophosphamide (low certainty).
1 finding from 1 review
Adverse effects: leucopenia · SSNS in children
It is very uncertain whether alkylating agents changes adverse effects: leucopenia compared with cyclosporin (very low certainty).
1 finding from 1 review